Search clinical trials for: LTX-315 (Oncopore™)

Total 130 results

Lytix Biopharma AS
Karolinska University Hospital; Oslo University Hospital

Completed

Dose-escalation Study of LTX-315 in Patients With a Transdermally Accessible Tumour

Cancer With Transdermal Accessible Tumour

Sweden, Norway
Verrica Pharmaceuticals Inc.
Instat Clinical Research; HeartcoR Solutions; Myonex; Vial Health Technology, Inc

Recruiting

Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma

Carcinoma | Skin Cancer | Basal Cell Carcinoma | Cancer of the Skin, Basal Cell | Cancer of the Skin

United States
Lytix Biopharma AS
Herlev Hospital

Completed

LTX-315 and Adoptive T-cell Therapy in Advanced Soft Tissue Sarcoma (ATLAS-IT-04)

Soft Tissue Sarcoma

Denmark
Lytix Biopharma AS
Kael-GemVax Co., Ltd.

Completed

A Study, Combination, Immunologic Study of LTX-315 as Adjunct to GV1001 in Patients Following Curative Surgery for Carcinoma

Carcinoma

Norway
Lytix Biopharma AS
ICON plc; Theradex

Completed

LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab

Melanoma | Lymphoma | Cancer | Breast Cancer | Head and Neck Cancer | Triple-Negative Breast Cancer

United Kingdom, France, Norway, Belgium, Italy
Boston Children's Hospital

Recruiting

Interstage Monitoring Using an Implantable Loop Recorder: A Pilot Study

Univentricular Heart

United States
Cook Group Incorporated

Completed

Zilver® PTX™ Global Registry

Peripheral Arterial Disease | Peripheral Vascular Disease

Germany, Italy
Calcilytix Therapeutics, Inc., a BridgeBio company

Completed

Safety, Tolerability, and Efficacy of Encaleret in Participants With Autosomal Dominant Hypocalcemia (ADH) Type 1

Autosomal Dominant Hypocalcemia (ADH)

United States
Takeda

Completed

Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.

Chronic Insomnia

United States
Takeda

Terminated

Efficacy of Ramelteon in Adults With Chronic Insomnia

Chronic Insomnia

United States
Takeda

Completed

Efficacy of Ramelteon on Speeding Up Sleep in Subjects With Delayed Sleep Phase Syndrome

Sleep Disorders, Circadian Rhythm

United States
Takeda

Completed

Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia

Chronic Insomnia

United States, Canada
Takeda

Completed

Efficacy of Ramelteon on Transient Insomnia in Healthy Adults

Transient Insomnia

United States
Takeda

Completed

Safety and Efficacy Study of Ramelteon in Subjects With Chronic Insomnia

Sleep Initiation and Maintenance Disorders
Cook Group Incorporated

Terminated

Evaluation of the GTX™ 5126 DES Coronary Stent System in the Treatment of Patients With a Lesion in the Coronary Artery

Coronary Artery Disease

Germany
Dentsply Sirona Implants and Consumables

Completed

Study on OsseoSpeed™ TX Implants in the Upper Jaw in a Chinese Population

Partially Edentulous Jaw

China
Dentsply Sirona Implants and Consumables

Completed

Study on OsseoSpeed™ TX Narrow Implants in the Upper Jaw in a Chinese Population

Partially Edentulous Jaw

China
Takeda

Completed

Ramelteon in Adults With Chronic Insomnia

Chronic Insomnia

United States
Takeda

Completed

Study of Efficacy of Ramelteon in Adults With Chronic Insomnia

Chronic Insomnia

United States
Takeda

Completed

Safety and Efficacy of Ramelteon in Healthy Subjects

Sleep Disorder

United States
Takeda

Completed

Efficacy of Ramelteon on Insomnia Symptoms Associated With Jet Lag in Healthy Adult Volunteers

Circadian Dysregulation

United States
Dentsply Sirona Implants and Consumables

Completed

Study on OsseoSpeed™ TX Narrow Implants in the Lower Jaw in a Chinese Population

Partially Edentulous Jaw

China
Takeda

Completed

Safety of Ramelteon in Subjects With Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease

United States
Dentsply Sirona Implants and Consumables

Completed

Study Evaluating OsseoSpeed™ Narrow Implant in the Upper and Lower Anterior Jaw

Jaw, Edentulous, Partially

Denmark, Germany, Italy, Spain, Sweden, United Kingdom
Becton, Dickinson and Company

Completed

Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens

Uterine Cervical Neoplasms

United States
Centre Hospitalier Universitaire Saint Pierre

Recruiting

Nociception Level Index (NOL Index) for Obstetrical Pain Assessment Under Epidural Analgesia.

Epidural Analgesia | Labor Pain | Nociceptive Pain | NOL Index

Belgium
Takeda

Completed

Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease

Chronic Obstructive Pulmonary Disease | COPD

United States
Brno University Hospital

Completed

Endoluminal Radiofrequency Ablation for the Treatment of Malignant Biliary Stenosis

Biliary Tract Cancer | Radiofrequency Ablation | Brachytherapy | Stent Complication

Czechia
Lytix Biopharma AS
Laboratory Corporation of America; OWL

Active, not recruiting

Intratumoral Injection of LTX-315 in Combination With Pembrolizumab in Advanced Melanoma (ATLAS-IT-05)

Advanced Melanoma

United States, Spain, France, Norway
Cook Group Incorporated
William Cook Europe; MED Institute, Incorporated; Cook Japan Incorporated

Completed

Evaluation of the Zilver PTX Drug-Eluting Stent in the Above-the-Knee Femoropopliteal Artery (Zilver PTX)

Peripheral Vascular Diseases

United States, Japan, Germany
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-029) (PNEU-PED)

Pneumococcal Infections | Pneumococcal Vaccines

United States, Puerto Rico, Thailand, Turkey
Medtronic Spinal and Biologics

Completed

TELAMON P™ Implant/INFUSE® Bone Graft/CD HORIZON® Spinal System Pilot Study

Degenerative Disc Disease
Emergent BioSolutions
Department of Health and Human Services

Completed

Safety Study of 7 Botulinum Antitoxin Serotypes Derived From Horses

Healthy

United States
Heat Biologics

Withdrawn

A Phase 1 Study of PTX-35 in Healthy Volunteers

Healthy Volunteer
Medtronic Endovascular

Completed

Study of the SilverHawk™ /TurboHawk™ Plaque Excision Systems Used With SpiderFX to Treat Calcified Peripheral Arterial Disease (DEFINITIVE Ca++)

Peripheral Arterial Disease
Pelican Therapeutics, Inc.

Terminated

PTX-35 in Patients With Advanced Solid Tumors

Advanced Solid Tumor

United States
Dentsply Sirona Implants and Consumables

Completed

Study on OsseoSpeed™ TX Short Implants in a Chinese Population

Partially Edentulous Jaw

China
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025) (PNEU-PED-EU-1)

Pneumococcal Infections

Australia, Belgium, Czechia, Estonia, Germany, Greece, Poland, Russian Federation, Spain
Boston Scientific Corporation
EKOS Corporation

Withdrawn

Registry Study to Evaluate the Performance and Safety of Roxwood Medical Catheters in Arteries of Participants With a Stenotic Lesion or Chronic Total Occlusion (CTO)

Coronary Artery Disease | Atherosclerosis | Peripheral Artery Disease | Chronic Total Occlusion

United States
Rabin Medical Center
Rambam Health Care Campus; Hillel Yaffe Medical Center; US Department of Veterans... and other collaborators

Completed

Capsule Endoscopy Crohn's Disease Activity Index - Validation Multi Center Study

Crohn's Disease

Israel, Ireland
Becton, Dickinson and Company

Completed

Comparison of Glycemic Control Among Diabetics Using Three Different Pen Needles

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

United States
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of V114 in Children Infected With Human Immunodeficiency Virus (HIV) (V114-030/PNEU-WAY PED) (PNEU-WAY PED)

Pneumococcal Infections

South Africa, Thailand, Ukraine
Maastricht University Medical Center

Withdrawn

Magnetic Resonance Imaging for Lymph Node Staging in Ovarian Cancer (MILO)

Ovarian Neoplasms

Netherlands
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)

Pneumococcal Infections

United States, Australia, Belgium, Brazil, Canada, Colombia, France, Germany, Mexico, Sweden
Eurocine Vaccines AB

Completed

Study to Assess the Safety, Tolerability and Immune Response Following Vaccination With Immunose™ FLU

Influenza, Human

Sweden
Stem Cell Therapeutics Corp.

Terminated

REGENESIS (CA): A Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS)

Stroke

Canada, India
Stem Cell Therapeutics Corp.

Withdrawn

REGENESIS (US): A Phase IIb Prospective, Randomized, Double-blind, Placebo Controlled Study of NTx™-265: Human Chorionic Gonadotropin (hCG) and Epoetin Alfa (EPO) in Acute Ischemic Stroke Patients (REGENESIS)

Stroke

United States
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026) (PNEU-PED-EU-2)

Pneumococcal Infections

Denmark, Finland, Italy, Norway, Sweden
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety and Tolerability of V114 and Prevnar 13™ in Healthy Infants (V114-031/PNEU-LINK)

Pneumococcal Infections

United States, Australia, Canada, Finland, Germany, Israel, Malaysia, Peru, Taiwan, Thailand
Medtronic Spinal and Biologics

Completed

MAVERICK™ Total Disc Replacement- Pivotal Study

Spinal Diseases

United States

Search clinical trials for: LTX-315 (Oncopore™)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ghana

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations